Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
68.4
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPNet Sales210,870Millions of yenYear on year +13.0%Progress 49.0%
Operating profit13,112Millions of yenYear on year +68.4%Progress 61.3%
Ordinary income12,764Millions of yenYear on year +72.8%Progress 64.5%
Net income attributable to owners of the parent11,682Millions of yenYear on year +105.1%Progress 67.1%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥60.87
Financial position at period-end
Total assets518,871Millions of yen
of which net assets 268,147 Millions of yenEquity ratio 49.4%vs. prior year-end -1.1pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+5,225
Investment-111
Financials-14,050
Net change-8,936
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period61,634 Millions of yen
Segment revenueTakara Shuzo 59,669 Millions of yen (YoY +3.3%), Takara Shuzo International Group 125,051 Millions of yen (YoY +20.4%), Takara Bio Group 19,525 Millions of yen (YoY +3.9%), Other 16,330 Millions of yen (YoY +4.7%)
Segment profitTakara Shuzo 2,638 Millions of yen (YoY +7.1%), Takara Shuzo International Group 9,479 Millions of yen (YoY +42.4%), Takara Bio Group -593 Millions of yen, Other 1,889 Millions of yen (YoY +10.6%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales430,000 Millions of yen (YoY +9.0%)
Operating profit21,400 Millions of yen (YoY +25.3%)
Ordinary income19,800 Millions of yen (YoY +17.4%)
Net income17,400 Millions of yen (YoY +48.8%)
Revision to Earnings ForecastNet Sales 420,000 Millions of yen → 430,000 Millions of yen（+2.4%） / Operating profit 18,800 Millions of yen → 21,400 Millions of yen（+13.8%） / Ordinary income 17,000 Millions of yen → 19,800 Millions of yen（+16.5%） / Net income 11,900 Millions of yen → 17,400 Millions of yen（+46.2%）
Annual Dividend Forecast31 Yen → 34 Yen（+9.7%）
Shareholder Return PolicyReduce the cost of capital through the use of interest-bearing debt and shareholder return measures funded by the sale of strategic shareholdings and owned real estate.
Factors Behind Changes in Business Performance
Higher revenue at the Takara Shuzo International Group, price revisions, tariff refunds in the United States, an increase in dividends received, the foreign exchange loss recorded in the same period of the previous year becoming a foreign exchange gain in the current period, and the recognition of deferred tax assets.
Disclosure regarding the going concern assumption
No matters to report.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNo material changes
Material subsequent eventsPartial transfer of shares in Takara Logistics System Co., Ltd. and transfer of 18 real estate properties.
Impairment lossNo impairment loss was recognized in the current period. ¥3,870 million was recognized by the Takara Bio Group in the same period of the previous year.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sales of investment securities 3,653 Millions of yen, Other 902 Millions of yen / Extraordinary loss Business Restructuring Costs 2,090 Millions of yen, Tender offer-related expenses 819 Millions of yen, Other 193 Millions of yen
Depreciation and amortization6,374 Millions of yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End197,252,043
Treasury Shares at Period-End5,807,731
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | 210,870 Millions of yen (YoY +13.0%) |
| Operating profit | 13,112 Millions of yen (YoY +68.4%) |
| Ordinary income | 12,764 Millions of yen (YoY +72.8%) |
| Profit attributable to owners of the parent | 11,682 Millions of yen (YoY +105.1%) |
| Net income per share | ¥60.87 |
| Equity ratio | End of the current fiscal period 49.4 / End of previous period 50.5 |
| Total assets | 518,871 Millions of yen |
| Net assets | 268,147 Millions of yen |
| Cash flows from operating activities | 5,225 Millions of yen |
| Cash flows from investing activities | -111 Millions of yen |
| Cash flows from financing activities | -14,050 Millions of yen |
| Cash and cash equivalents at end of period | 61,634 Millions of yen |
| Full-year earnings forecast | Net Sales 430,000 Millions of yen (YoY +9.0%) / Operating profit 21,400 Millions of yen (YoY +25.3%) / Ordinary income 19,800 Millions of yen (YoY +17.4%) / Net income 17,400 Millions of yen (YoY +48.8%) |
| Revision to Earnings Forecast | Net Sales 420,000 Millions of yen → 430,000 Millions of yen（+2.4%） / Operating profit 18,800 Millions of yen → 21,400 Millions of yen（+13.8%） / Ordinary income 17,000 Millions of yen → 19,800 Millions of yen（+16.5%） / Net income 11,900 Millions of yen → 17,400 Millions of yen（+46.2%） |
| Annual Dividend Forecast | 31 Yen → 34 Yen（+9.7%） |
| Shareholder Return Policy | Reduce the cost of capital through the use of interest-bearing debt and shareholder return measures funded by the sale of strategic shareholdings and owned real estate. |
| Segment revenue | Takara Shuzo 59,669 Millions of yen (YoY +3.3%), Takara Shuzo International Group 125,051 Millions of yen (YoY +20.4%), Takara Bio Group 19,525 Millions of yen (YoY +3.9%), Other 16,330 Millions of yen (YoY +4.7%) |
| Segment profit | Takara Shuzo 2,638 Millions of yen (YoY +7.1%), Takara Shuzo International Group 9,479 Millions of yen (YoY +42.4%), Takara Bio Group -593 Millions of yen, Other 1,889 Millions of yen (YoY +10.6%) |
| Depreciation and amortization | 6,374 Millions of yen |
| Impairment loss | No impairment loss was recognized in the current period. ¥3,870 million was recognized by the Takara Bio Group in the same period of the previous year. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sales of investment securities 3,653 Millions of yen, Other 902 Millions of yen / Extraordinary loss Business Restructuring Costs 2,090 Millions of yen, Tender offer-related expenses 819 Millions of yen, Other 193 Millions of yen |
| Disclosure regarding the going concern assumption | No matters to report. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes |
| Material subsequent events | Partial transfer of shares in Takara Logistics System Co., Ltd. and transfer of 18 real estate properties. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 197,252,043 |
| Treasury Shares at Period-End | 5,807,731 |
| Factors Behind Changes in Business Performance | Higher revenue at the Takara Shuzo International Group, price revisions, tariff refunds in the United States, an increase in dividends received, the foreign exchange loss recorded in the same period of the previous year becoming a foreign exchange gain in the current period, and the recognition of deferred tax assets. |
Items this document does not state (4)
Operating MarginPayout ratioRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was attributable to higher revenue at the Takara Shuzo International Group, tariff refunds in the United States, an increase in dividends received, the foreign exchange loss recorded in the same period of the previous year becoming a foreign exchange gain in the current period, and the recognition of deferred tax assets.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.